Abstract
Gastric cancer is one of the aggressive tumors which has a poor prognosis due to the late detection. It is asymptomatic cancer and most of the cases gastric cancer are diagnosed at advanced stages. From the usual invasive methods of screening, the use of saliva as a non-invasive diagnostic method is gaining much attention. Nowadays researches have shed light on the use of saliva as a diagnostic tool and many studies have identified various salivary biomarkers for the early detection of gastric cancer. But the lack of validated biomarkers in this field can be considered as a drawback, which can be dealt with the enhancement of preclinically validated biomarkers by assimilating them to credible biomarker panels.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Advances in Cancer Research & Clinical Imaging
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
